Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

"The unmet medical need in OM is tremendous and we look forward to advancing Brilacidin-OM toward possible market approval, which would help improve the lives of so many cancer patients.” - Dr B.

Probably over thinking this (and admittedly naive to requirements) but any chance this could mean they are angling toward accelerated/conditional approval, rolling review, etc? Or is that out of the question and the simplest interpretation, that they will now move to a P3 and then hopefully garner FDA approval, the only thing implied here?